Back to 
HRT FINANCIAL LP
HRT FINANCIAL LP
STLN
2 quarters
Position history for HRT FINANCIAL LP's holdings in Starling Oncology, Inc.
No. HRT Financial exited its STLN (Starling Oncology) position in Q2 2025. Its Q1 2025 13F listed 16,658 shares worth $18,000. HRT Financial first reported STLN in Q1 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$18,000
Total Shares Change
-16,658
Quarter-by-Quarter History